Advertisement
Research Article| Volume 17, ISSUE 4, P727-735, December 1997

Why Cardiospecificity is Preeminent in Myocardial Markers of Injury

  • Joseph H. Keffer
    Correspondence
    Address reprint requests to Joseph H. Keffer, MD, Chief Medical Officer and Vice President, Spectral Diagnostics, Inc., 135-2 The West Mall, Toronto, Ontario M9C 1C2 Canada
    Affiliations
    From Spectral Diagnostics, Inc., Toronto, Ontario, Canada
    Search for articles by this author
DOI:https://doi.org/10.1016/S0272-2712(18)30194-X
Why Cardiospecificity is Preeminent in Myocardial Markers of Injury
Previous ArticleSpectrum of Ischemic Heart Disease and The Role of Biochemical Markers
Next ArticleTroponin, Where Do We Go From Here?
      This paper is only available as a PDF. To read, Please Download here.
      The most critical facet of a biochemical marker of ischemic heart disease is cardiospecificity. This flows from the fact that symptoms and alternative objective studies including coronary arteriography and electrocardiography are frequently insensitive in detecting coronary artery disease. The timely appearance of biochemical evidence of myocyte necrosis firmly asserts the presence of life threatening multi-focal coronary atherosclerosis which is often not otherwise knowable. Compliance in the response of physician and patient clearly depend on the perception of persuasive biochemical testimony.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Laboratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Ambrose J.A.
        • Fuster V.
        Can we predict future acute coronary events in patients with stable coronary artery disease? [editorial].
        JAMA. 1997; 277: 343-344
        • Ambrose J.A.
        • Tannenbaum M.A.
        • Alexopoulos D.
        • et al.
        Angiographie progression of coronary artery disease and the development of myocardial infarction.
        J Am Coll Cardiol. 1988; 12: 56-62
        • Antman E.M.
        • Grudzien C.
        • Mitchell R.N.
        • Sacks D.B.
        Detection of unsuspected myocardial necrosis by rapid bedside assay for cardiac troponin T.
        Am Heart J. 1997; 133: 596-598
        • Antman E.M.
        • Tanasijevic M.J.
        • Thompson B.
        • et al.
        Cardiac specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes.
        N Engl J Med. 1996; 335: 1342-1349
        • Braunwald E.B.
        Heart Disease: A Textbook of Cardiovascular Medicine.
        Philadelphia, WB Saunders1997
        • Collins P.
        • Rosano G.M.
        • Sarrel P.M.
        • et al.
        17-ß-Estradiol attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary artery disease.
        Circulation. 1995; 92: 24-30
        • Davies M.J.
        • Thomas A.C.
        Plaque fissuring: The cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina.
        Br Heart J. 1985; 53: 363-373
        • Davies M.J.
        • Thomas A.C.
        • Knapman P.A.
        • Hangartner A.R.
        Intramyocardial platelet aggregation in patients with unstable angina suffering sudden ischemic cardiac death.
        Circulation. 1986; 3: 417-418
        • Falk E.
        • Shah P.K.
        • Fuster V.
        Coronary plaque disruption.
        Circulation. 1995; 92: 657-671
        • Galvani M.
        • Ottani F.
        • Ferrini D.
        • et al.
        Prognostic influence of elevated values of cardiac troponin I in patients with unstable angina.
        Circulation. 1997; 95: 2053-2059
        • Gerhardt W.
        • Katus H.
        • Ravkilde J.
        • et al.
        S-troponin T in suspected ischemic myocardial injury compared with mass and catalytic concentrations of S-creatine kinase isoenzyme MB.
        Clin Chem. 1991; 37: 1405-1411
        • Hamm C.
        • Ravkilde J.
        • Gerhardt W.
        • et al.
        The prognostic value of serum troponin T in unstable angina.
        N Engl J Med. 1992; 327: 146-150
        • Hoeg J.M.
        Evaluating coronary heart disease risk.
        Presented for grand rounds at the Clinical Center of the National Institutes of Health. JAMA. 1997; 277: 1387-1390
        • Hofgren C.
        • Karlson B.W.
        • Herlitz J.
        Prodromal symptoms in subsets of patients hospitalized for suspected acute myocardial infarction.
        Heart Lung. 1995; 24: 3-10
        • Hong R.A.
        • Licht J.D.
        • Wei J.Y.
        • et al.
        Elevated CK-MB with normal total creatine kinase in suspected myocardial infarction: Associated clinical findings and early prognosis.
        Am Heart J. 1986; 111: 1041-1046
        • Isikawa Y.
        • Saffitz J.E.
        • Mealman T.L.
        • et al.
        Reversible myocardial ischemic injury is not associated with increased creatine kinase activity in plasma.
        Clin Chem. 1997; 43: 467-475
        • Keffer J.H.
        The cardiac profile and proposed practice guideline for acute ischemic heart disease.
        Am J Clin Pathol. 1997; 107: 398-409
        • Libby P.
        Molecular basis of the acute coronary syndromes.
        Circulation. 1995; 91: 2844-2850
        • Nakagomi A.
        • Celermajer D.S.
        • Lumley T.
        • et al.
        Angiographic severity of coronary narrowing is a surrogate marker for the extent of coronary atherosclerosis.
        Am J Cardiol. 1996; 78: 516-519
        • Ohman E.M.
        • Armstrong P.W.
        • Christenson R.H.
        • et al.
        Cardiac troponin T levels for risk stratification in acute myocardial ischemia.
        N Engl J Med. 1996; 335: 1333-1341
        • O'Keefe Jr, J.H.
        • Conn R.D.
        • Lavie Jr, C.J.
        • Bateman T.M.
        The new paradigm for coronary artery disease: Altering risk factors, atherosclerotic plaques, and clinical prognosis.
        Mayo Clin Proc. 1996; 71: 957-965
        • O'Keefe Jr, J.H.
        • Nelson J.
        • Harris W.S.
        Lifestyle change for coronary artery disease: What to tell patients.
        Postgrad Med. 1996; 99: 89-106
        • Senni M.
        • Redfield M.M.
        Congestive heart failure in elderly patients.
        Mayo Clin Proc. 1997; 72: 453-460
        • Spaulding C.H.
        • Joly L.-M.
        • Rosenberg A.
        • et al.
        Immediate coronary angiography in survivors of out-of-hospital cardiac arrest.
        N Engl J Med. 1997; 336: 1629-1633
        • Spodick D.H.
        Q-wave infarction versus ST-infarction: Nonspecificity of electrocardiographic criteria for differentiating transmural and nontransmural lesions.
        Am J Cardiol. 1983; 51: 913-915
        • Stone P.H.
        • Thompson B.
        • Anderson H.V.
        • et al.
        Influence of race, sex, and age of management of unstable angina and non-Q-wave myocardial infarction.
        The TIMI III Registry. JAMA. 1996; 275: 1104-1112
        • Treasure C.B.
        • Klein J.L.
        • Weintraub W.S.
        • et al.
        Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease.
        N Engl J Med. 1995; 332: 481-487

      28. Tunstall-Pedoe H: A coronary heart attack register in East London. Thesis, 1977, Cambridge University, Great Britain. Reprint by Health Sciences, Medicine & Surgery

      Article info

      Identification

      DOI: https://doi.org/10.1016/S0272-2712(18)30194-X

      Copyright

      © 1997 Elsevier Inc. Published by Elsevier Inc. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect

      The content on this site is intended for healthcare professionals.


      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


      RELX